Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03077503 |
Date of registration:
|
04/03/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Comparison of Dexmedetomidine and Fentanyl to Prevent Hemodynamic Response to Skull Pins Application
|
Scientific title:
|
Comparison of Dexmedetomidine and Fentanyl to Prevent Hemodynamic Response to Skull Pins Application in Neurosurgery:Double Blind Randomized Controlled Trial |
Date of first enrolment:
|
September 1, 2015 |
Target sample size:
|
60 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03077503 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Thailand
| | | | | | | |
Contacts
|
Name:
|
Pornthep Kasemsiri, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Khon Kaen University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients who scheduled for elective craniotomy under general anesthesia
- patient with American Society of Anesthesiologists physical status classification of I
and II
Exclusion Criteria:
- patients having body mass index more than 30 kg/m2, heart rate lower than 45 bpm,
hypertension, ischemic heart disease, heart block, on beta adrenergic blockers,
medication allergy including propofol, fentanyl, and dexmedetomidine.
Age minimum:
18 Years
Age maximum:
64 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Hemodynamic Response
|
Skull Pins Application
|
Intervention(s)
|
Drug: Fentanyl
|
Drug: 0.9% normal saline
|
Device: Skull pins
|
Drug: Dexmedetomidine
|
Primary Outcome(s)
|
Change in blood pressure
[Time Frame: Baseline in time frame before pin insertion (T1-T4) , time during pin insertion (T5), repeated measurement time every 1 minute until 5 minutes after pin applications (T6-T10).]
|
Secondary Outcome(s)
|
Change in heart rate
[Time Frame: Baseline in time frame before pin insertion (T1-T4), time during pin insertion (T5), repeated measurement time every 1 minute until 5 minutes after pin applications (T6-T10).]
|
Change in mean arterial pressure
[Time Frame: Baseline in time frame before pin insertion (T1-T4), time during pin insertion (T5), repeated measurement time every 1 minute until 5 minutes after pin applications (T6-T10).]
|
adverse events
[Time Frame: Baseline in time frame before pin insertion (T1-T4), time during pin insertion (T5), repeated measurement time every 1 minute until 5 minutes after pin applications (T6-T10).]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|